Mohammadreza Ghaffarzadeh-Esfahani

DrugGen-2 redefines drug discovery by integrating disease context, yielding molecules with binding affinities that surpass traditional reference drugs.

You can extract clinical features from low-resource languages with surprisingly high accuracy (F1 > 0.89) by pairing a translation model with off-the-shelf small language models, even without fine-tuning.

Generative AI can now design AAV capsids with enhanced kidney targeting, thermostability, and production fitness, opening new avenues for precision gene therapy.